Final Results of the Canadian Myeloma Research Group Trial of Cybord Induction, Double-Alkylator Conditioning with High-Dose Intravenous Busulfan + Melphalan, ASCT and Continuous Lenalidomide Maintenance for Patients with Newly Diagnosed Multiple Myeloma (CMRG-001)
Bibliographic record
Abstract
Introduction: Real-world CMRG Database results in patients (pts) with newly diagnosed multiple myeloma (NDMM) treated with the previous Canadian standard regimen of CyBorD induction, high-dose melphalan (HD-Mel) + single ASCT followed by lenalidomide (len) maintenance until progression/toxicity yielded a benchmark median PFS of 4.5 and median OS of 9.4 years (yrs) (Cote J, et al. Blood Cancer J 2023; 13:137). The CMRG-001 trial was designed over a decade ago to try to optimize results in ASCT-eligible NDMM patients (pts). Study pts received the same standard induction in use during this time (typically weekly CyBorD) as well as len maintenance 10 mg daily until disease progression/toxicity, but the pre-ASCT conditioning consisted of double-alkylator HD therapy with intravenous (IV) busulfan and melphalan (BuMel) rather than HD-Mel (Reece D, et al. Blood 2019; 134 [Suppl 1]: 4570). Results: Between 03/2013-05/2016, 78 pts were entered. Median age was 57 yrs (range 34-69); 51 (65.4%) were male; median beta-2 microglobulin level was 3.07 mg/L (range 1.7-20). High-risk (HR) FISH cytogenetics were identified in 15 (19.2%) pts and consisted of t(4;14) in 9 (11.5%), t(14;16) in 7 (9%) and del17p in 4 (5%); 5 pts had 2 HR features. Median follow-up is now 7.2 yrs (range 0.4-8.9). The PFS rates at 5 and 8 yrs after ASCT are 60% (95% CI 48-70%) and 43% (95% CI 30-56%), respectively. The median PFS for those with standard-risk (SR) FISH has not yet been reached compared with 4 yrs for HR pts. In SR pts, the 5-yr PFS is 66% (95% CI 52-76%) and 8-yr PFS 50.2% (95% CI 35-64%), compared with the respective PFS rates in HR individuals of 32% (95% CI 10-57%) and 11% (7-37%) (p=0.008). No difference in PFS between HR pts with 1 versus 2 HR FISH aberrations was observed (p=0.41), although pt numbers were small. No early transplant-related mortality occurred. Twenty-three events of secondary primary malignancies (SPMs) have been diagnosed in 20 pts (including 1 pt with both colon and 3 non-melanoma skin cancers) as follows: skin cancers in 8 (1 melanoma and 7 non-melanoma [all resolved]), 7 heme malignancies (4 AML, 1 ALL, 1 Hodgkin's disease, 1 diffuse large B cell lymphoma) and 8 adenocarcinomas (1 prostate, 1 endocervical in situ, 2 colon, 1 lung, 1 pancreas, 2 unknown primary). Median time from ASCT until diagnosis of any SPM was 2.76 yrs, and 3.71 yrs in those with invasive/systemic SPMs; 5 of these pts had already discontinued len maintenance for other reasons. Nineteen (24.4%) of the 78 pts have died. The most common cause of death was MM progression (9 pts) while 7 pts succumbed to an SPM (2 from AML, 1 from ALL, 1 from Hodgkin's disease and 3 from adenocarcinoma). The median time from ASCT to death from SPM was 4.2 yrs. The other 3 deaths were due to pulmonary embolism in 1 pt and unknown causes in 2 pts. The median OS in all pts has not yet been reached. The 5- and 8-yr OS rates are 81% (95% CI 70-88%) and 71.5% (95% CI 59-81%). When evaluated by FISH cytogenetic risk, 5- and 8-yr OS rates are 85% (95% CI 73-90%) and 76% (95% CI 61-85%) for SR pts and 63% (95% CI 32-83%) and 54% (95% CI 24-76%) in HR pts, respectively (p=0.043). Summary/Conclusions: 1) Despite the caveats with cross-trial comparisons, the median PFS of 7.4 yrs and 5- and 8-yr OS rates of 81% and 71.5% with IV BuMel conditioning before ASCT compare favorably with our prior real-world Canadian benchmarks using similar CyBorD induction and len maintenance until progression but pre-ASCT conditioning with HD-Mel alone without Bu; 2) the results are not dissimilar to those reported with RVD induction, single ASCT using HD-Mel conditioning, RVD consolidation and continuous len maintenance (median PFS 5.6 yrs and 5-yr OS 79.2%; Richardson PG, et al. NEJM 2022; 387:132); 3) while just over half of the SR pts are alive without progression 8 yrs post-ASCT, the PFS and OS in HR pts remain suboptimal; 4) better preventative strategies are needed to reduce the incidence of fatal SPMs; 4) the PFS/OS survival results suggest a strong anti-myeloma effect of IV BuMel conditioning before ASCT, particularly given the absence of RVD before/after ASCT in this trial; 5) future ASCT studies evaluating IV BuMel conditioning with optimal induction, integration of immunotherapy and/or modified len maintenance schedules–perhaps based on factors such as MRD status–may be of interest.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.003 | 0.002 |
| Meta-epidemiology (narrow) | 0.001 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.001 |
| Bibliometrics | 0.000 | 0.001 |
| Science and technology studies | 0.001 | 0.001 |
| Scholarly communication | 0.002 | 0.000 |
| Open science | 0.001 | 0.000 |
| Research integrity | 0.001 | 0.002 |
| Insufficient payload (model declined to judge) | 0.005 | 0.001 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".